03 Jan 2008 Acambis reports positive data from trials of universal influenza A vaccine
31 Dec 2007 IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
27 Dec 2007 Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
24 Dec 2007 Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
21 Dec 2007 Curalogic announces top line results from Phase III clinical study with the
21 Dec 2007 Aeras and Crucell Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras commits a further USD 5 million to the development of the tuberculosis vaccine
20 Dec 2007 Successful Collaboration between US Army and Intercell Towards a Novel Vaccine Against JE
20 Dec 2007 Novavax Announces Favorable Interim Results From Human Clinical Trial
20 Dec 2007 Genitope Corporation Reports Initial Results of Phase 3 Clinical Trial of MyVax(R) Personalized Immunotherapy
19 Dec 2007 GlobeImmune Announces Initiation of Phase II Clinical Trial of GI-5005 in Patients with Chronic Hepatitis C
17 Dec 2007 Lilly and BioMS Medical Announce Global Licensing and Development Agreement
17 Dec 2007 GlaxoSmithKline receives FDA 'complete response' letter for cervical cancer vaccine
16 Dec 2007 Intercell receives Milestone Payment from Merck & Co. Inc.
14 Dec 2007 IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
12 Dec 2007 Geron receives milestone payment from merck triggered by ind filing for telomerase cancer vaccine candidate
10 Dec 2007 Oxford Biomedica Announces Data Safety Monitoring Board Recommendation to ContinueTroVax(R) Phase III Trial in Renal Cancer
07 Dec 2007 Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
06 Dec 2007 AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
06 Dec 2007 Nventa completes enrollment and initial dosing of second cohort in phase 1 hspE7 safety trial
04 Dec 2007 SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
29 Nov 2007 Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
29 Nov 2007 Cytos Biotechnology announces start of two phase II studies
28 Nov 2007 Oralair(R) Grasses: Positive results of VO52.06 paediatric study
27 Nov 2007 Nventa updates progress with new HspE7 in Phase 1 trial in cervical dysplasia
27 Nov 2007 Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up